A Randomised, Double-Blind, Phase III, Comparative Trial Of 2 Doses Of ZD1839 (Iressa) In Combination With Gemcitabine and Cisplatin Versus Placebo In Combination With Gemcitabine And Cisplatin In Chemotherapy-Naive Patients With Advanced (Stage III or IV) Non-Small Cell Lung Cancer.

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.

Vivli为一家独立的非营利组织，已搭建全球数据共享与分析平台，以服务国际科研共同体的全维度需求。本组织的使命是：通过打造并落地可持续的全球数据共享体系，推动、协调并促进临床研究数据的科学共享与复用。Vivli平台涵盖独立数据存储库、深度搜索引擎及基于云端的安全分析平台。